PureTech Share News (PRTC)

PureTech Information

Buy PRTC Shares
Add PRTC to Watchlist
Add PRTC to Alert

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 225.00

Bid: 224.50

Ask: 226.50

Change: -1.50 (-0.66%)

Spread: 2.00 (0.891%)

Open: 226.50

High: 226.50

Low: 225.00

Prev. Close: 226.50

Last checked at -

UK earnings, trading statements calendar - next 7 days

Tue, 22nd Aug 2023 15:46

Wednesday 23 August
Angling Direct PLC	Trading Statement
Costain Group PLC	Half Year Results
Thursday 24 August
Benchmark Holdings PLC	Q3 Results
CRH PLC	Half Year Results
Harbour Energy PLC	Half Year Results
Hays PLC	Full Year Results
Hunting PLC	Half Year Results
James Cropper PLC	Half Year Results
Macfarlane Group PLC	Half Year Results
Princess Private Equity Holding Ltd	Half Year Results
Redcentric PLC	Full Year Results
South32 Ltd	Full Year Results
Tribal Group PLC	Half Year Results
Friday 25 August
no events scheduled
Monday 28 August
no events scheduled
Tuesday 29 August
Amaroq Minerals Ltd	Half Year Results
Bunzl PLC	Half Year Results
Dalata Hotel Group PLC	Half Year Results
Faron Pharmaceuticals Ltd	Half Year Results
PureTech Health PLC	Half Year Results

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

20 Mar 2023 16:01

PureTech Health says Karuna KArXT trial receives positive results

(Alliance News) - PureTech Health PLC on Monday said its founded entity, Karuna Therapeutics Inc announced its phase 3 EMERGENT-3 trial of KarXT in Schizophrenia has met its primary endpoint.

28 Feb 2023 21:05

TRADING UPDATES: Eco Atlantic swings to loss; Curtis approves takeover

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

14 Feb 2023 13:27

IN BRIEF: PureTech Health to start trials for anxiety, depression drug

PureTech Health PLC - clinical-stage biotherapeutics company - Says it will advance LYT-300 for the potential treatment of anxiety disorders and post-partum depression. A placebo-controlled, phase 2a, proof-of-concept, social anxiety clinical trial is expected to begin in the first half of 2023. Results are expected by the end of the year. An open-label, phase 2a, proof-of-concept clinical trial in women with post-partum depression is expected to begin in the second half of 2023.

6 Jan 2023 18:31

PureTech's Alkili reports success in adolescent ADHD study

(Sharecast News) - Clinical-stage biotherapeutics investor PureTech Health announced on Friday today that its digital medicine company Akili, which it founded, announced topline results of the 'STARS-ADHD-Adolescents' label expansion study evaluating the efficacy and safety of 'EndeavorRx', or 'AKL-T01' in adolescents aged 13 to 17 with attention-deficit hyperactivity disorder (ADHD).

6 Jan 2023 08:52

PureTech says ADHD treatment shows improved attentional functioning

(Alliance News) - PureTech Health PLC on Friday said the topline results for the pivotal trial of its EndeavorRx treatment showed "robust improvements in attention and broader clinical outcomes".

23 Dec 2022 18:15

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

9 Dec 2022 16:35

PureTech entity Sonde raises USD19.3 million in investment round

(Alliance News) - PureTech Health PLC on Friday said that its founded entity, Sonde Health Inc, has completed a Series B investment round for the development of its voice-based health monitoring technology.

8 Dec 2022 10:15

PureTech founded entity Vor Bio first AML patient gets transplant

(Alliance News) - PureTech Health PLC on Thursday announced that its founded entity Vor Biopharma Inc has successfully transplanted its investigational trem-Cel into a patient with acute myeloid leukemia.

30 Nov 2022 17:33

PureTech Health advances new therapeutic candidate to clinical studies

(Alliance News) - PureTech Health PLC on Wednesday said that it had advanced LYT-310, an oral form of cannabidiol (CBD) prodrug toward clinical studies.

13 Oct 2022 10:14

LONDON BROKER RATINGS: Mondi and Smurfit Kappa raised, DS Smith cut

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

13 Oct 2022 07:50

LONDON BRIEFING: Entain looks to World Cup; easyJet revenue improves

(Alliance News) - Stocks in London were called lower on Thursday as investors look ahead to an afternoon which may deliver the final nail in the coffin for hopes of a dovish tilt by the US Federal Reserve.

11 Oct 2022 17:09

LONDON MARKET CLOSE: Stocks down; IMF warns "the worst is yet to come"

(Alliance News) - Stock prices in London closed lower on Tuesday, as storm clouds gathered over the global economic outlook, as UK fiscal policy also faces increasing scrutiny.

11 Oct 2022 09:00

PureTech Health takeover talks with Nektar Therapeutics end

(Alliance News) - PureTech Health PLC on Tuesday said takeover talks with San Francisco-based biopharmaceutical company Nektar Therapeutics have been terminated.

11 Oct 2022 08:46

LONDON MARKET OPEN: Stocks struggle again amid BoE bond market warning

(Alliance News) - Stock prices in London opened lower on Tuesday, while the pound was on the back foot as the Bank of England once again attempted to calm a tetchy, and now "stability" threatening, bond market.

11 Oct 2022 08:09

UPDATE: LONDON BRIEFING: Bank of England widens bond buying

(Alliance News) - The mood in global markets remained dark early Tuesday, with poor sessions in New York and Asia set to spill over to the European open.

Latest Share Chat

PureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account